Page last updated: 2024-10-29

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Leukemia, Megakaryoblastic, Acute

4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline has been researched along with Leukemia, Megakaryoblastic, Acute in 1 studies

WHI P131: a quinazoline derivative, inhibitor of glioblastoma cell adhesion and migration

Leukemia, Megakaryoblastic, Acute: An acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. MYELOFIBROSIS or increased bone marrow RETICULIN is common.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, T1
Toki, T1
Kanezaki, R1
Xu, G1
Terui, K1
Kanegane, H1
Miura, M1
Adachi, S1
Migita, M1
Morinaga, S1
Nakano, T1
Endo, M1
Kojima, S1
Kiyoi, H1
Mano, H1
Ito, E1

Other Studies

1 other study available for 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline and Leukemia, Megakaryoblastic, Acute

ArticleYear
Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.
    British journal of haematology, 2008, Volume: 141, Issue:5

    Topics: Base Sequence; Cell Proliferation; Dose-Response Relationship, Drug; Down Syndrome; Female; Humans;

2008